Published • loading... • Updated
Cancer Cell Diagnostics Launches New Blood Test for Cancer Profiling
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cancer Cell Diagnostics Launches New Blood Test for Cancer Profiling
The test uses intact circulating tumor cells instead of cell-free DNA fragments to analyze more than 500 genes and identify tumor markers. Cancer Cell Diagnostics announced the commercial launch of CellSight DNA, a genomic profiling test that uses intact circulating tumor cells isolated from a standard blood draw. While most blood-based cancer tests analyze cell-free circulating tumor DNA—the degraded fragments tumors shed into the bloodstream—t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
